English | Español

Community
+ Community
Patient Daily | Apr 24, 2023

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2023 Financial Results on May 10, 2023
+ Community
Patient Daily | Apr 24, 2023

Certara to Report First Quarter 2023 Financial Results on May 8th, 2023 and Participate in the BofA Securities 2023 Healthcare Conference
+ Community
Patient Daily | Apr 24, 2023

Tandem Diabetes Care to Present at the BofA Securities 2023 Health Care Conference
+ Community
Patient Daily | Apr 24, 2023

2022 GHX Millennium Club Honorees Are Transforming the Healthcare Supply Chain
+ Community
Patient Daily | Apr 24, 2023

Horizon Therapeutics plc Announces UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be Presented at the 2023 American Academy of Neurology (AAN) Annual Meeting
+ Community
Patient Daily | Apr 24, 2023

Horizon Therapeutics plc and Massachusetts Institute of Technology (MIT) Solve Announce the Launch of the Third Annual Horizon Prize to Inspire Sustainable Solutions for Research and Care in the Rare Disease Community
+ Community
Patient Daily | Apr 24, 2023

Kaia Health Named As Top Digital Therapeutics Company by AVIA Marketplace
+ Community
Patient Daily | Apr 21, 2023

Precision Value & Health Acquires Makara Health, Expanding the Company’s Footprint and Communications Capabilities in Europe

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes